Evaluation of increased arterial stiffness in pediatric patients with cystic fibrosis by augmentation index and pulse wave velocity analysis

Basit Öğe Kaydı
dc.contributor.authorOzturk, Gokcen Kartal
dc.contributor.authorConkar, Secil
dc.contributor.authorEski, Aykut
dc.contributor.authorGulen, Figen
dc.contributor.authorKeskinoglu, Ahmet
dc.contributor.authorDemir, Esen
dc.date.accessioned2020-12-01T12:02:30Z
dc.date.available2020-12-01T12:02:30Z
dc.date.issued2020
dc.departmentEge Üniversitesien_US
dc.description.abstractWith the increase in life expectancy, cardiovascular complications of cystic fibrosis (CF) have come to the forefront. Increased arterial stiffness is a marker of increased cardiovascular risk. the aim of this study was to compare both pulse wave velocity (PWV) and augmentation index (Aix) measurements in children with CF and to compare them with healthy controls. We hypothesized that children with CF had increased arterial stiffness, although traditional risk factors for CVD were not observed. Forty-four patients and age and sex-matched 30 healthy controls were included in the study. Hemodynamic measurements were compared in both groups, together with traditional risk factors. Peripheral blood pressure parameters of CF and control groups were similar (P > .05). Bodyweight and BMI were significantly lower in the CF group (P < .001). Serum cholesterol, HDL, and LDL levels were significantly lower in the CF group, whereas fasting blood glucose and triglyceride levels were significantly higher than the control group (P < .05). Mean +/- SD Aix was significantly higher in the CF group (33.22 +/- 13.87%) compared with the control group (24.93 +/- 10.58%), respectively (P < .05), while PWV was similar. No significant correlation between PWV and Aix and fasting blood glucose and lipid profile in both groups (P > .05). Children with CF have been shown to have increased arterial stiffness compared to healthy children. Although there are not many traditional risk factors, increased arterial stiffness have been demonstrated in children with CF. the effects of this process starting from childhood on the development of CVD in adulthood are not known. Therefore, further studies are needed.en_US
dc.identifier.doi10.1002/ppul.24688en_US
dc.identifier.endpage1153en_US
dc.identifier.issn8755-6863
dc.identifier.issn1099-0496
dc.identifier.issue5en_US
dc.identifier.pmid32057197en_US
dc.identifier.scopus2-s2.0-85079523208en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1147en_US
dc.identifier.urihttps://doi.org/10.1002/ppul.24688
dc.identifier.urihttps://hdl.handle.net/11454/62694
dc.identifier.volume55en_US
dc.identifier.wosWOS:000513257500001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofPediatric Pulmonologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectarterial stiffnessen_US
dc.subjectaugmentation indexen_US
dc.subjectcystic fibrosisen_US
dc.subjectpulse wave velocity analysisen_US
dc.titleEvaluation of increased arterial stiffness in pediatric patients with cystic fibrosis by augmentation index and pulse wave velocity analysisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu